BioSpace News Archive

GW Pharmaceuticals plc, a world leader in the science, development, and commercialization of cannabinoid prescription medicines, announces financial results for the fourth quarter and full-year ended December 31, 2019.

Sunesis Pharmaceuticals, Inc. announced that Willie Quinn, Chief Financial Officer and Senior Vice President, Finance and Corporate Development of Sunesis, will present at the 40th Annual Cowen Health Care Conference on Tuesday, March 3, 2020 at 10:00 AM Eastern Standard Time in Boston, Massachusetts.

Full year 2019 GOCOVRI® product sales of $54.6 million, a 60% increase over 2018; total paid prescriptions grew approximately 66% to 25,780

Evolent Health, Inc., a health care company that delivers proven clinical and administrative solutions to payers and providers, announced financial results for the quarter and full year ended December 31, 2019.

Jazz Pharmaceuticals plc announced financial results for the full year and the fourth quarter of 2019 and provided financial guidance for 2020.

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® Brasil, in partnership with the Consulate General of Brazil in Houston, sponsored “Autism Together We Are Stronge

Company Presentation on Thursday, February 27, 2020 at 11:00 AM Eastern Time

Medical video game company kicks off 2020 with key hire from Amazon and Microsoft, and new 20,000+-square-foot office space

In collaboration with JHU, Capsulomics will advance pre-cancer and cancer-detection technology licensed in 2019

Feb. 25, 2020 14:15 UTC Honored by Training magazine for ninth consecutive year WILMINGTON, N.C.--( BUSINESS WIRE )-- PPD, Inc. (Nasdaq:PPD), has been named to Training magazine’s 2020 Training Top 125 list , recognizing organizations that excel at employee training and development. “PPD empowers our greatest asset, our talented and committed employees, to achieve a culture of high performance that enables exceptional service delivery for our pharmaceutical and bi